倍氯米松/福莫特羅/格隆溴銨
| 組成 | |
|---|---|
| 二丙酸倍氯米松 | 糖皮質激素 |
| 延胡索酸福莫特羅二水合物 | 長效β2激動劑 |
| 格隆溴銨 | 抗毒蕈鹼劑 |
| 臨床資料 | |
| 商品名 | Trimbow、Trydonis、Riarify等等 |
| AHFS/Drugs.com | 英國藥物信息 |
| 給藥途徑 | 吸入 |
| ATC碼 | |
| 法律規範狀態 | |
| 法律規範 |
|
| 識別資訊 | |
| CAS號 | 2447629-85-6 |
倍氯米松/福莫特羅/格隆銨，以Trimbow等商品名銷售，是一種用於治療慢性阻塞性肺病（COPD）和哮喘的吸入式固定劑量複方藥。它含有二丙酸倍氯米松、延胡索酸福莫特羅二水合物和格隆溴銨。[3][4]
副作用包括口腔念珠菌症（由念珠菌引起的口腔真菌感染）、肌肉痙攣和口乾。[3][4]
倍氯米松/福莫特羅/格隆銨於2017年7月和2018年4月在歐盟獲准使用。[3][4][5]
參考資料[編輯]
- ^ Trimbow ARTG ID 314166. Therapeutic Goods Administration (TGA). [21 July 2020].
- ^ Trimbow 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution - Summary of Product Characteristics (SmPC). (emc). 8 February 2019 [5 March 2020].
- ^ 3.0 3.1 3.2 Trimbow EPAR. European Medicines Agency (EMA). 5 March 2020 [5 March 2020]. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ^ 4.0 4.1 4.2 Trydonis EPAR. European Medicines Agency (EMA). 21 July 2020 [21 July 2020]. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
- ^ Riarify EPAR. European Medicines Agency (EMA). [21 July 2020].
外部連結[編輯]
- Beclometasone dipropionate. Drug Information Portal. U.S. National Library of Medicine.
- Formoterol. Drug Information Portal. U.S. National Library of Medicine.
- Glycopyrronium bromide. Drug Information Portal. U.S. National Library of Medicine.